Opsis Therapeutics

Opsis Therapeutics

Retinal degenerative diseases cause irreversible vision loss in tens of millions of patients worldwide. Our mission at Opsis Therapeutics is to advance a pipeline of first-in-class cell replacement therapies targeting Age-Related Macular Degeneration (AMD) and a broad range of inherited retinal disorders including Retinitis Pigmentosa. Opsis technology platform builds upon recent advances that enable scalable manufacture of authentic human retinal cells from induced-pluripotent stem cells.

Company details

525 Science Dr,,Madison,53717

Find locations servedoffice locations

Business Type:
Manufacturer
Industry Type:
Pharmaceuticals
Market Focus:
Globally (various continents)
Year Founded:
2016

Contact supplier

Drop file here or browse